Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
2022-07-02 11:4:20 am As amyloid-targeting therapies for Alzheimer's fail, where might success lie? SeekingAlpha
Jun-24-22 04:30PM AC Immune Holds Annual General Meeting of Shareholders GlobeNewswire
Jun-21-22 10:35AM 10 Unknown Biotech Stocks That Can Explode in 2022 Insider Monkey
Jun-17-22 08:31AM Roche Alzheimer's Candidate Failure Hurts Lilly, Biogen Zacks
Jun-16-22 08:20AM Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients Benzinga
Jun-16-22 06:39AM AC Immune shares slide 15% premarket after trial of Alzheimer's treatment misses its main goals MarketWatch
Jun-16-22 01:00AM AC Immune Provides Update on Alzheimers Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimers Disease GlobeNewswire
Jun-01-22 08:26AM We're Not Very Worried About AC Immune's (NASDAQ:ACIU) Cash Burn Rate Simply Wall St.
May-31-22 07:30AM AC Immune to Present at the 2022 Jefferies Healthcare Conference GlobeNewswire
May-17-22 09:00AM AC Immune CEO Andrea Pfeifer Receives Aenne Burda Award GlobeNewswire
May-09-22 11:00AM AC Immunes Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology GlobeNewswire
Apr-28-22 07:30AM AC Immune Reports First Quarter 2022 Financial Results and Provides Corporate Update GlobeNewswire
Apr-27-22 07:55AM AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference GlobeNewswire
Apr-08-22 07:30AM AC Immune Reports Changes to Senior Management GlobeNewswire
Mar-30-22 07:58AM AC Immune KOL Webinar on First Clinical Proof of Concept for Alpha-synuclein Diagnostic Shows Breakthrough Potential for Neurodegenerative diseases GlobeNewswire
Mar-22-22 07:30AM AC Immune Reports Full Year 2021 Financial Results and Provides Corporate Update GlobeNewswire
Mar-21-22 07:30AM AC Immune to Host Key Opinion Leader Webinar on Alpha-Synuclein as a Target in Neurodegenerative Diseases GlobeNewswire
Mar-16-22 07:41AM AC Immune Reports First Live Images of Alpha-Synuclein in Human Brain with New PET Tracer for Neurodegenerative Disease at AD/PDTM Conference GlobeNewswire
Feb-28-22 07:30AM AC Immune to Present at the AD/PD 2022 New Clinical and Preclinical Data for Alpha-Synuclein, Abeta and TDP-43 Programs GlobeNewswire
Feb-21-22 04:30AM Could The AC Immune SA (NASDAQ:ACIU) Ownership Structure Tell Us Something Useful? Simply Wall St.
Feb-15-22 02:54PM AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial Benzinga
Feb-15-22 07:30AM AC Immune ACI-35.030 Phase 1b/2a Trial Interim Data Confirm Consistent Safety and Potent Immunogenicity of pTau Alzheimers Vaccine in High-dose Cohort GlobeNewswire
Feb-04-22 07:30AM AC Immune ACI-24 Data in Brain Communications Show Abeta Vaccine-Candidate Induces Immunity Against pyroGlu-Abeta, Key Driver of Alzheimers Disease GlobeNewswire
Feb-02-22 08:58AM AC Immune to Present at the SVB Leerink 11th Annual Global Healthcare Conference GlobeNewswire
Dec-15-21 07:49AM AC Immune Awarded Two Michael J. Fox Foundation Grants to Advance Small Molecule Parkinsons Disease Programs GlobeNewswire
Nov-15-21 06:01AM 10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund Insider Monkey
Nov-12-21 08:21AM AC Immune Announces Interim Phase 1b/2a Data Showing that its ACI-35.030 Anti-pTau Alzheimers Vaccine Generates a Potent Immune Response GlobeNewswire
Nov-10-21 11:20AM AC Immune Announces Late-Breaker Presentation by Genentech at CTAD on Phase 2 Lauriet Study of Semorinemab in Mild-to-Moderate Alzheimers Disease GlobeNewswire
Nov-08-21 08:25AM AC Immune (ACIU) Reports Q3 Loss, Misses Revenue Estimates Zacks
Nov-08-21 07:00AM AC Immune Reports Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Nov-07-21 07:53AM AC Immune says number of families affected by Alzheimer's could nearly triple by 2050 Reuters
Nov-05-21 03:00PM Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline Zacks
Nov-04-21 06:00AM AC Immune Extends Research Collaboration with University of Pennsylvania Focusing on the Pathogenic Protein TDP-43, a Major Driver of Neurodegenerative Diseases GlobeNewswire
Nov-02-21 07:30AM New Data on AC Immunes Abeta and pTau Clinical Programs in Alzheimers Disease To Be Presented at CTAD 2021 GlobeNewswire
Oct-29-21 06:00AM AC Immune Holds its Extraordinary General Meeting and Appoints Monica Shaw, M.D., and Prof. Monika Bütler, Dr. oec., to its Board of Directors GlobeNewswire
Oct-25-21 07:00AM AC Immune to Present at the Jefferies London Healthcare Conference GlobeNewswire
Oct-24-21 08:04AM Shareholders in AC Immune (NASDAQ:ACIU) are in the red if they invested five years ago Simply Wall St.
Sep-03-21 07:52AM AC Immune CEO Andrea Pfeifer Receives First SEF.WomenAward for CEO of the Year GlobeNewswire
Sep-02-21 07:00AM AC Immune to Participate in Upcoming Virtual Investor Conferences in September GlobeNewswire
Sep-01-21 11:30AM AC Immune's (ACIU) Stock Up Despite Mixed Data From AD Study Zacks
Sep-01-21 10:44AM Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More Zacks
Aug-31-21 04:03PM Why A Roche-Partnered Alzheimer's Drug Sent AC Immune Stock Flying Investor's Business Daily
Aug-31-21 03:40PM What Leerink, Wainwright Have To Say For This Alzheimer's Focused Firm Benzinga
Aug-31-21 12:13PM Mid-Day Market Update: Zoom Shares Drop After Q2 Results; AC Immune Shares Surge Benzinga
Aug-31-21 12:05PM 33 Stocks Moving In Tuesday's Mid-Day Session Benzinga
Aug-31-21 11:06AM Here's Why AC Immune Stock Is Surging Today Motley Fool
Aug-31-21 10:22AM Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates Benzinga
Aug-31-21 07:59AM See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate Benzinga
Aug-31-21 07:30AM AC Immune Announces First Positive Cognitive Results for a Tau-Targeting Monoclonal Antibody in Alzheimers Disease GlobeNewswire
Aug-04-21 08:25AM AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates Zacks
Aug-04-21 07:00AM AC Immune Reports Second Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Jul-29-21 07:30AM AC Immune Presents Full Phase 1b Results on Anti-Abeta Vaccine and Discusses its First-in-Class Diagnostic for Parkinsons Disease at AAIC 2021 GlobeNewswire
Jul-28-21 03:03PM Earnings Preview: AC Immune (ACIU) Q2 Earnings Expected to Decline Zacks
Jul-27-21 09:27AM AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate Benzinga
Jul-27-21 08:00AM AC Immune acquires AFFiRiS Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases GlobeNewswire
Jul-27-21 07:30AM AC Immune Announces Strategic Acquisition of Industry-leading Parkinsons Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH GlobeNewswire
Jul-26-21 01:22AM What Is The Ownership Structure Like For AC Immune SA (NASDAQ:ACIU)? Simply Wall St.
Jun-25-21 08:38AM AC Immune Holds its Annual General Meeting of Shareholders GlobeNewswire
Jun-02-21 07:34AM AC Immune Stock Jumps After Alzheimer's Disease Vaccine Candidate Confirms Favorable Safety, Tolerability Profile Benzinga
Jun-02-21 07:00AM AC Immune Provides Update on Alzheimers Disease Vaccine Candidates Targeting Pathological Amyloid-Beta GlobeNewswire
May-27-21 01:11AM Is AC Immune (NASDAQ:ACIU) In A Good Position To Invest In Growth? Simply Wall St.
May-20-21 07:00AM AC Immune to Highlight First-in-Class Alzheimers Disease Vaccine Programs at Upcoming Investor Conferences GlobeNewswire
May-17-21 09:55AM AC Immune Provides Update On Alzheimer's Disease Vaccine Candidate Benzinga
May-17-21 07:00AM AC Immune Announces Expansion of Phase 1b/2a phospho-Tau Alzheimers Vaccine Trial and Provides a Program Update GlobeNewswire
Apr-28-21 08:45AM AC Immune (ACIU) Reports Q1 Loss, Misses Revenue Estimates Zacks
Apr-28-21 07:00AM AC Immune Reports First Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Apr-20-21 12:00PM AC Immune (ACIU) Moves to Buy: Rationale Behind the Upgrade Zacks
Mar-31-21 07:00AM AC Immune Hosts Investor Webinar Highlighting the Power of its Morphomer Platform to Enable Precision Medicine for Neurodegenerative Disease GlobeNewswire
Mar-28-21 03:00AM These Analysts Just Made A Sizeable Downgrade To Their AC Immune SA (NASDAQ:ACIU) EPS Forecasts Simply Wall St.
Mar-26-21 07:00AM AC Immune to Host Webinar Highlighting its Innovative Morphomer Technology Platform and Pipeline GlobeNewswire
Mar-25-21 01:28AM Did You Miss AC Immune's (NASDAQ:ACIU) 27% Share Price Gain? Simply Wall St.
Mar-23-21 08:01AM Recap: AC Immune Q4 Earnings Benzinga
Mar-23-21 07:00AM AC Immune Reports Full-Year 2020 Financial Results and Provides 2021 R&D Outlook GlobeNewswire
Mar-16-21 07:00AM AC Immune Announces New Clinical Results in Down Syndrome and Plans for Future Development of Anti-Amyloid-Beta Vaccine GlobeNewswire
Mar-09-21 07:00AM AC Immune Presents New Preclinical Data for Therapeutic and Diagnostic Candidates Addressing Novel Targets for Neurodegenerative Diseases GlobeNewswire
Feb-24-21 07:00AM AC Immune to Present New Data from Alpha-Synuclein and TDP-43 Programs at the AD/PD 2021 Virtual Conference GlobeNewswire
Feb-17-21 07:00AM AC Immune to Highlight Promising Alzheimers Vaccine at the SVB Leerink 10th Annual Global Healthcare Conference GlobeNewswire
Feb-11-21 08:24PM Why AC Immune Stock Surged Today Motley Fool
Feb-11-21 04:23PM This Dollar-Stock Biotech Popped In Bullish Volume On Its Alzheimer's News Investor's Business Daily
Feb-11-21 08:16AM AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally Benzinga
Feb-11-21 07:00AM AC Immunes Alzheimers Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study GlobeNewswire
Feb-08-21 07:00AM AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinsons Disease GlobeNewswire
Jan-29-21 07:00AM AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway GlobeNewswire
Jan-24-21 01:01AM New Forecasts: Here's What Analysts Think The Future Holds For AC Immune SA (NASDAQ:ACIU) Simply Wall St.
Jan-17-21 11:13PM What Kind Of Shareholders Own AC Immune SA (NASDAQ:ACIU)? Simply Wall St.
Dec-15-20 08:00AM AC Immune Receives Competitive Target ALS Foundation Grant to Accelerate the Development of Proprietary Phosphorylated TDP-43 Immuno-assay GlobeNewswire
Dec-11-20 12:54PM Is ACIU A Good Stock To Buy Now? Insider Monkey
Nov-20-20 08:40AM Immunotherapy Pioneer Prof. Carl H. June Joins AC Immunes Board of Directors GlobeNewswire
Nov-18-20 07:00AM Neurologist and Psychiatrist Prof. Johannes Rolf Streffer, MD Joins AC Immune SA as Chief Medical Officer GlobeNewswire
Nov-13-20 10:10AM AC Immune (ACIU) Reports Q3 Loss, Tops Revenue Estimates Zacks
Nov-13-20 07:27AM AC Immune: Q3 Earnings Insights Benzinga
Nov-13-20 07:00AM AC Immune Reports Q3 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-12-20 07:00AM AC Immune to Provide Strategy and Pipeline Update During Jefferies Virtual London Healthcare Conference GlobeNewswire
Nov-09-20 04:00AM AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immunes Anti-TDP-43 Antibodies into Clinical Development GlobeNewswire
Nov-04-20 12:30PM Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline Zacks
Oct-09-20 08:25AM Competitive EU Grant Supports Collaboration to Accelerate Development of AC Immune's First-in-Class TDP-43 Diagnostic Agent GlobeNewswire
Oct-05-20 06:39AM Companies Like AC Immune (NASDAQ:ACIU) Are In A Position To Invest In Growth Simply Wall St.
Sep-24-20 10:35AM AC Immune's Candidate Fails in Alzheimer's Disease Study Zacks
Sep-23-20 10:19AM Why AC Immune Stock Is Crashing Today Motley Fool
Sep-23-20 07:00AM AC Immune Reports Top Line Results from TAURIEL Phase 2 Trial Evaluating Semorinemab in Early Alzheimers Disease GlobeNewswire
Sep-11-20 07:00AM AC Immune to Showcase Anti-Tau Portfolio at H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire